Patent · US Active

Recombinant chemokine-antigen vaccine

US8133873B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

Cancer Institute, Chinese Academy of Medical Sciences · CN

Inventors

Shuren ZHANG · Beijing, CN
Chen-Yong Lin · Falls Church, US
Wenxin Sun · Beijing, CN
Hanjun Qin · Beijing, CN
Chunxia Zhou · Shandong, CN
Xiao Liang · Redmond, US
Dongmei Wang · Beijing, CN
Wenbo Ma · Tangxia, CN
Xueyan Zhang · Baofeng County, CN
Ming Fu · Beijing, CN

Key dates

Filing date	May 9, 2005
Grant date	Mar 13, 2012
Priority date	—
Expiry date	Aug 8, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/806
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A recombinant gene sequence that comprises human SLC gene, antigen gene, and IgG1-Fc fragment gene, wherein the SLC gene is linked upstream to the antigen gene, and the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.